2024-10-01 2025-09-30 false No description of principal activity Acting Office - Tax and Accounts 1.0 12862031 bus:FullAccounts 2024-10-01 2025-09-30 12862031 bus:Micro-entities 2024-10-01 2025-09-30 12862031 bus:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 12862031 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 12862031 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 12862031 2024-10-01 2025-09-30 12862031 2025-09-30 12862031 bus:RegisteredOffice 2024-10-01 2025-09-30 12862031 core:WithinOneYear 2025-09-30 12862031 core:AfterOneYear 2025-09-30 12862031 2023-10-01 12862031 bus:Director1 2024-10-01 2025-09-30 12862031 bus:Director1 2025-09-30 12862031 bus:Director1 2023-10-01 2024-09-30 12862031 bus:Director2 2024-10-01 2025-09-30 12862031 bus:Director2 2025-09-30 12862031 bus:Director2 2023-10-01 2024-09-30 12862031 bus:Director3 2024-10-01 2025-09-30 12862031 bus:Director3 2025-09-30 12862031 bus:Director3 2023-10-01 2024-09-30 12862031 bus:CompanySecretary1 2024-10-01 2025-09-30 12862031 bus:LeadAgentIfApplicable 2024-10-01 2025-09-30 12862031 2023-10-01 2024-09-30 12862031 2024-09-30 12862031 core:WithinOneYear 2024-09-30 12862031 core:AfterOneYear 2024-09-30 12862031 bus:EntityAccountantsOrAuditors 2023-10-01 2024-09-30 12862031 core:ComputerSoftware 2024-10-01 2025-09-30 12862031 core:ComputerSoftware 2025-09-30 12862031 core:ComputerSoftware 2024-09-30 12862031 core:CostValuation core:Non-currentFinancialInstruments 2025-09-30 12862031 core:CostValuation core:Non-currentFinancialInstruments 2024-09-30 12862031 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-09-30 12862031 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-09-30 12862031 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-09-30 12862031 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-09-30 12862031 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2025-09-30 12862031 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2025-09-30 12862031 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-09-30 12862031 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-09-30 12862031 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-09-30 12862031 core:Non-currentFinancialInstruments 2025-09-30 12862031 core:Non-currentFinancialInstruments 2024-09-30 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 12862031
England and Wales
Unaudited Financial Statements
for the year ended 30 September 2025
for
APRICUS MED-TECH UK LTD

APRICUS MED-TECH UK LTD ###### Statement of Financial Position As at 30 September 2025
|  | £ | 2025 £ |  | £ | 2024 £
--- | --- | --- | --- | --- | --- | ---
Fixed assets |  |  | 34,565 |  |  | 48,071
Current assets |  | 4,220 |  |  | 15,958 |
Creditors: amount falling due within one year |  | (479) |  |  | (479) |
Net current assets/(liabilities) |  |  | 3,741 |  |  | 15,479
Total assets less current liabilities |  |  | 38,306 |  |  | 63,550
Creditors: amount falling due after more than one year |  |  | (84,711) |  |  | (84,711)
Net assets/(liabilities) |  |  | (46,405) |  |  | (21,161)
Capital and reserves |  |  | (46,405) |  |  | (21,161)
For the year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime. Signed on behalf of the board of directors:
--------------------------------------------- Prashant Bhand Director |  |
Date approved: 02 April 2026 1

APRICUS MED-TECH UK LTD ###### Notes to the Accounts For the year ended 30 Sep 2025
Statutory Information Apricus Med-Tech Uk Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number 12862031, registration address 116 Harold Hines Way, Trentham, Stoke-On-Trent, ST4 8ZL, United Kingdom. The presentation currency is £ sterling.
1. | Accounting Policies Basis of accounting The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016). Going Concern The financial statements have been prepared on a going concern basis. The company's ongoing activities are dependent upon the continued support of the directors who have undertaken to provide such support for the foreseeable future. If the going concern basis were not appropriate, adjustments would have to be made to reduce the value of assets to their recoverable amount, to provide for any further liabilities that may arise and to reclassify fixed assets as current assets and long term liabilities as current liabilities. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Website cost Planning and operating costs for the company's website are charged to the profit and loss account as incurred. Cost of sales Intangible assets Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.
2. | Intangible fixed assets
Cost or Valuation |  | Computer software |  | Total
|  | £ |  | £
At 01 October 2024 |  | 67,529 |  | 67,529
Additions |  | - |  | -
At 30 September 2025 |  | 67,529 |  | 67,529
Amortisation
At 01 October 2024 |  | 19,458 |  | 19,458
Charge for year |  | 13,506 |  | 13,506
At 30 September 2025 |  | 32,964 |  | 32,964
Net book values
At 30 September 2025 |  | 34,565 |  | 34,565
At 30 September 2024 |  | 48,071 |  | 48,071
3. | Average number of employees Average number of employees during the year was 0 (2024: 0).
2